Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05457582
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2022-07-07
Brief Title:
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Organization Data
Organization:
Nanjing First Hospital Nanjing Medical University
Class:
OTHER
Study ID:
NMU20220701
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing First Hospital Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Shaoliang Chen MD
Responsible Party Title:
Vice President of Nanjing First Hospital Director of Cardiovascular Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanjing First Hospital Nanjing Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nanjing Medical University | OTHER |
| National Natural Science Foundation of China | OTHER_GOV |